ICD-10 Coding for Dilated Pancreatic Duct(C25.3, C25.3B, C25.3M)
Learn about the ICD-10 coding and documentation requirements for dilated pancreatic duct, including primary and secondary codes, clinical validation, and common pitfalls.
Complete code families applicable to Dilated Pancreatic Duct
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| K86.1 | Chronic pancreatitis | Use when duct dilation is due to chronic pancreatitis. |
|
| R90.89 | Other abnormal findings on diagnostic imaging | Use when the cause of duct dilation is unknown. |
|
| C25.3 | Malignant neoplasm of pancreatic duct | Use when duct dilation is due to confirmed pancreatic cancer. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutDilated Pancreatic Duct
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Dilated Pancreatic Duct.
Omitting etiology in documentation
Impact
Clinical: Leads to misdiagnosis and inappropriate treatment., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims.
Mitigation
Always include the underlying cause of duct dilation if known.
Using R90.89 when etiology is known
Impact
Reimbursement: May lead to incorrect DRG assignment and reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of clinical data.
Mitigation
Use specific codes like K86.1 or C25.3 when the cause is identified.
Use of unspecified codes
Impact
Frequent use of R90.89 without supporting documentation.
Mitigation
Ensure imaging reports are included in the patient's record.